AE Wealth Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,698
Closed -$434K 2190
2024
Q4
$434K Buy
4,698
+2,119
+82% +$208K ﹤0.01% 949
2024
Q3
$249K Sell
2,579
-707
-22% -$63.5K ﹤0.01% 1095
2024
Q2
$282K Sell
3,286
-6
-0.2% -$504 ﹤0.01% 1051
2024
Q1
$272K Sell
3,292
-2,681
-45% -$196K ﹤0.01% 992
2023
Q4
$428K Sell
5,973
-408
-6% -$26.4K ﹤0.01% 1535
2023
Q3
$429K Buy
6,381
+1,350
+27% +$92.9K ﹤0.01% 1460
2023
Q2
$341K Sell
5,031
-844
-14% -$52.9K ﹤0.01% 1555
2023
Q1
$318K Sell
5,875
-15,289
-72% -$890K ﹤0.01% 1527
2022
Q4
$1.27M Buy
21,164
+1,073
+5% +$58.4K 0.01% 898
2022
Q3
$909K Buy
+20,091
New +$1.01M 0.01% 977
2021
Q4
Sell
-4,250
Closed -$254K 1717
2021
Q3
$254K Sell
4,250
-1,373
-24% -$86.4K ﹤0.01% 1428
2021
Q2
$349K Sell
5,623
-4,130
-42% -$275K ﹤0.01% 1280
2021
Q1
$635K Buy
9,753
+417
+4% +$27.2K 0.01% 923
2020
Q4
$614K Buy
9,336
+897
+11% +$52.8K 0.01% 887
2020
Q3
$436K Buy
8,439
+3,220
+62% +$165K 0.01% 920
2020
Q2
$257K Buy
+5,219
New +$282K ﹤0.01% 1076

Other funds holding EHC

AE Wealth Management's EHC Position: Q1 2025 in Review

AE Wealth Management sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 4,698 shares — an estimated $434K sold.

AE Wealth Management first reported a position in EHC in Q2 2020 and held it in 16 quarters. The position peaked at $1.27M in Q4 2022. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • AE Wealth Management reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
  • AE Wealth Management sold 4,698 Encompass Health shares in Q1 2025, an estimated $434K.
  • AE Wealth Management first reported a position in Encompass Health in Q2 2020 and held it in 16 quarters.
  • AE Wealth Management's Encompass Health position peaked at $1.27M in Q4 2022.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on AE Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.